AG˹ٷ

STOCK TITAN

[Form 4] EchoStar Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

UBS AG is offering unsecured, unsubordinated Capped Market-Linked Notes linked to the worse performer between the Nasdaq-100 Index (NDX) and the S&P 500 Index (SPX). The Notes price on 9 July 2025, settle on 14 July 2025 and mature on 14 January 2027 (final valuation 11 January 2027).

Return profile: at maturity investors receive the principal plus (i) the least-performing underlying return if positive, subject to a maximum gain of 15.20% (maximum payment $1,152); or (ii) the greater of the least-performing underlying return and a minimum return of �5.00% if the underlying return is zero or negative. Accordingly, principal is 95 % protected when held to maturity, but upside is capped.

Key economics: issue price $1,000; underwriting discount $6.50 (0.65 %); net proceeds $993.50. The estimated initial value is $959.40�$989.40, below issue price due to internal funding spreads and distribution costs. UBS Securities LLC is the underwriter and may re-allow the full discount to third-party dealers.

Risk considerations: investors bear the credit risk of UBS and market risk of each index on the final valuation date. The Notes pay no coupons, forgo all dividends, are not listed, and may exhibit limited or no secondary liquidity. Trades executed prior to settlement require T+3 settlement arrangements. The offering documents highlight additional risks under “Key Risks� and “Risk Factors.�

Investor suitability: appropriate only for investors who can tolerate up to a 5 % loss, accept capped upside, understand structured products, and intend to hold to maturity.

UBS AG offre Note di Mercato Indicizzate a Capitale Non Garantito e Non Subordinate, collegate alla performance peggiore tra l'indice Nasdaq-100 (NDX) e l'indice S&P 500 (SPX). Il prezzo delle Note è fissato al 9 luglio 2025, con regolamento il 14 luglio 2025 e scadenza il 14 gennaio 2027 (valutazione finale l'11 gennaio 2027).

Profilo di rendimento: alla scadenza gli investitori ricevono il capitale più (i) il rendimento dell'asset sottostante meno performante se positivo, con un guadagno massimo del 15,20% (pagamento massimo $1.152); oppure (ii) il maggiore tra il rendimento dell'asset meno performante e un rendimento minimo del �5,00% se il rendimento è nullo o negativo. Di conseguenza, il capitale è protetto al 95% se detenuto fino alla scadenza, ma il potenziale guadagno è limitato.

Elementi economici chiave: prezzo di emissione $1.000; sconto di sottoscrizione $6,50 (0,65%); proventi netti $993,50. Il valore iniziale stimato è tra $959,40 e $989,40, inferiore al prezzo di emissione a causa di spread di finanziamento interni e costi di distribuzione. UBS Securities LLC è il sottoscrittore e può concedere l'intero sconto ai dealer terzi.

Considerazioni sui rischi: gli investitori assumono il rischio di credito di UBS e il rischio di mercato di ciascun indice alla data di valutazione finale. Le Note non pagano cedole, rinunciano a tutti i dividendi, non sono quotate e potrebbero presentare una liquidità secondaria limitata o assente. Le operazioni eseguite prima del regolamento richiedono un regolamento T+3. I documenti di offerta evidenziano ulteriori rischi sotto le sezioni “Rischi Chiave� e “Fattori di Rischio�.

Idoneità per gli investitori: adatte solo a investitori che tollerano fino al 5% di perdita, accettano un guadagno limitato, comprendono i prodotti strutturati e intendono mantenere l'investimento fino alla scadenza.

UBS AG ofrece Notas Vinculadas al Mercado sin garantía y no subordinadas, vinculadas al peor desempeño entre el índice Nasdaq-100 (NDX) y el índice S&P 500 (SPX). El precio de las Notas es el 9 de julio de 2025, con liquidación el 14 de julio de 2025 y vencimiento el 14 de enero de 2027 (valoración final el 11 de enero de 2027).

Perfil de rendimiento: al vencimiento, los inversionistas reciben el capital más (i) el rendimiento del activo subyacente con peor desempeño si es positivo, sujeto a una ganancia máxima del 15.20% (pago máximo $1,152); o (ii) el mayor entre el rendimiento del activo con peor desempeño y un rendimiento mínimo de �5.00% si el rendimiento es cero o negativo. Por lo tanto, el capital está protegido al 95% si se mantiene hasta el vencimiento, pero la ganancia está limitada.

Aspectos económicos clave: precio de emisión $1,000; descuento de suscripción $6.50 (0.65%); ingresos netos $993.50. El valor inicial estimado es entre $959.40 y $989.40, por debajo del precio de emisión debido a spreads internos de financiamiento y costos de distribución. UBS Securities LLC es el suscriptor y puede permitir que terceros distribuidores reciban el descuento completo.

Consideraciones de riesgo: los inversionistas asumen el riesgo crediticio de UBS y el riesgo de mercado de cada índice en la fecha de valoración final. Las Notas no pagan cupones, renuncian a todos los dividendos, no están listadas y pueden tener liquidez secundaria limitada o nula. Las operaciones realizadas antes de la liquidación requieren un arreglo de liquidación T+3. Los documentos de oferta destacan riesgos adicionales bajo “Riesgos Clave� y “Factores de Riesgo�.

Idoneidad para inversores: apropiado solo para inversionistas que puedan tolerar hasta un 5% de pérdida, acepten ganancia limitada, comprendan productos estructurados y tengan la intención de mantener hasta el vencimiento.

UBS AG� 나스�-100 지�(NDX)와 S&P 500 지�(SPX) � 성과가 � 저조한 지수를 기초� 하는 무담�, 비후순위 캡드 마켓 연계 노트� 제공합니�. 노트 가격은 2025� 7� 9�� 책정되며, 결제일은 2025� 7� 14�, 만기일은 2027� 1� 14�입니� (최종 평가일은 2027� 1� 11�).

수익 프로�: 만기 � 투자자는 원금� 함께 (i) 성적� 가� 낮은 기초자산 수익�� 양수� 경우 최대 15.20%� 최대 이익(최대 지급액 $1,152)까지 받거�; (ii) 기초자산 수익률이 0이거� 음수� 경우 최소 수익률인 �5.00%와 가� 낮은 수익� � � � 금액� 받습니다. 따라� 만기까지 보유 � 원금� 95%가 보호되지� 상승 잠재력은 제한됩니�.

주요 경제 조건: 발행가 $1,000; 인수 할인 $6.50 (0.65%); 순수� $993.50. 초기 추정 가치는 내부 자금 조달 스프레드와 배포 비용으로 인해 $959.40~$989.40� 발행가보다 낮습니다. UBS Securities LLC가 인수사이� �3� 딜러에게 전액 할인� 재허용할 � 있습니다.

위험 고려사항: 투자자는 UBS� 신용 위험� 최종 평가일의 � 지수에 대� 시장 위험� 부담합니다. 노트� 쿠폰� 지급하지 않으�, 모든 배당금을 포기하고 상장되어 있지 않으� 2� 유동성이 제한적이거나 전혀 없을 � 있습니다. 결제 � 거래� T+3 결제 조건� 필요합니�. 제공 문서에는 “주� 위험� � “위� 요소”에� 추가 위험� 명시되어 있습니다.

투자� 적합�: 최대 5% 손실� 감수� � 있고, 수익 상한� 수용하며, 구조� 상품� 이해하고 만기까지 보유� 의사가 있는 투자자에� 적합합니�.

UBS AG propose des Notes Capped Market-Linked non garanties et non subordonnées, liées à la performance la moins favorable entre l'indice Nasdaq-100 (NDX) et l'indice S&P 500 (SPX). Le prix des Notes est fixé au 9 juillet 2025, le règlement au 14 juillet 2025 et l'échéance au 14 janvier 2027 (évaluation finale le 11 janvier 2027).

Profil de rendement : à l’échéance, les investisseurs reçoivent le capital plus (i) le rendement de l’actif sous-jacent le moins performant s’il est positif, avec un gain maximal de 15,20 % (paiement maximal de 1 152 $) ; ou (ii) le plus élevé entre le rendement de l’actif sous-jacent le moins performant et un rendement minimum de �5,00 % si le rendement est nul ou négatif. Par conséquent, le capital est protégé à 95 % s’il est conservé jusqu’� l’échéance, mais le potentiel de gain est plafonné.

Principaux aspects économiques : prix d’émission 1 000 $ ; escompte de souscription 6,50 $ (0,65 %) ; produit net 993,50 $. La valeur initiale estimée se situe entre 959,40 $ et 989,40 $, inférieure au prix d’émission en raison des écarts de financement internes et des coûts de distribution. UBS Securities LLC est le souscripteur et peut accorder l’intégralité de la décote aux distributeurs tiers.

Considérations sur les risques : les investisseurs supportent le risque de crédit d’UBS et le risque de marché de chaque indice à la date d’évaluation finale. Les Notes ne versent pas de coupons, renoncent à tous les dividendes, ne sont pas cotées et peuvent présenter une liquidité secondaire limitée ou nulle. Les transactions effectuées avant le règlement nécessitent un règlement T+3. Les documents d’offre mettent en lumière des risques supplémentaires dans les sections « Risques clés » et « Facteurs de risque ».

Adéquation pour les investisseurs : approprié uniquement pour les investisseurs pouvant tolérer une perte allant jusqu’� 5 %, acceptant un gain plafonné, comprenant les produits structurés et ayant l’intention de conserver jusqu’� l’échéance.

UBS AG bietet ungesicherte, nachrangfreie Capped Market-Linked Notes an, die an die schlechter performende der beiden Indizes Nasdaq-100 (NDX) und S&P 500 (SPX) gekoppelt sind. Der Preis der Notes wird am 9. Juli 2025 festgelegt, die Abwicklung erfolgt am 14. Juli 2025 und die Fälligkeit ist am 14. Januar 2027 (Endbewertung am 11. Januar 2027).

Renditeprofil: Bei Fälligkeit erhalten Anleger den Kapitalbetrag plus (i) die Rendite des schlechter performenden Basiswerts, falls diese positiv ist, begrenzt auf einen maximalen Gewinn von 15,20 % (maximale Auszahlung $1.152); oder (ii) den höheren Wert zwischen der Rendite des schlechteren Basiswerts und einer Mindestverzinsung von �5,00 %, falls die Rendite null oder negativ ist. Dementsprechend ist das Kapital bei Halten bis zur Fälligkeit zu 95 % geschützt, allerdings ist die Gewinnchance begrenzt.

Wesentliche wirtschaftliche Fakten: Ausgabepreis $1.000; Underwriting-Discount $6,50 (0,65 %); Nettoerlös $993,50. Der geschätzte Anfangswert liegt zwischen $959,40 und $989,40, also unter dem Ausgabepreis aufgrund interner Finanzierungsspreads und Vertriebskosten. UBS Securities LLC ist der Underwriter und kann den vollen Rabatt an Drittanbieter weitergeben.

Risikohinweise: Anleger tragen das Kreditrisiko von UBS und das Marktrisiko der jeweiligen Indizes am Endbewertungstag. Die Notes zahlen keine Kupons, verzichten auf alle Dividenden, sind nicht börsennotiert und können eine begrenzte oder keine Sekundärliquidität aufweisen. Vor der Abwicklung durchgeführte Trades erfordern T+3-Abwicklungsvereinbarungen. Die Angebotsunterlagen weisen unter „Wesentliche Risiken� und „Risikofaktoren� auf weitere Risiken hin.

Geeignetheit für Anleger: Nur geeignet für Anleger, die einen Verlust von bis zu 5 % tolerieren können, eine begrenzte Aufwärtschance akzeptieren, strukturierte Produkte verstehen und die Absicht haben, bis zur Fälligkeit zu halten.

Positive
  • 95 % principal protection at maturity limits maximum loss to 5 %.
  • Exposure to two major U.S. indices provides diversified equity linkage within a single note.
  • Defined maximum gain of 15.20 % offers clarity on potential upside.
  • Short 18-month tenor lowers duration and macro exposure compared with longer-dated structured notes.
Negative
  • Upside capped at 15.20 %, materially below potential index returns.
  • No interim coupons or dividends, reducing total yield versus direct equity ownership.
  • Credit risk of UBS AG; note is unsecured and unsubordinated.
  • Single-observation risk � performance measured only on final valuation date.
  • Limited secondary liquidity; notes will not be listed, and dealer pricing may be unfavorable.
  • Estimated initial value up to 4 % below issue price reflects embedded costs borne by investors.

Insights

TL;DR � Retail-focused structured note offers 95 % protection but caps upside at 15.2 %; credit and liquidity risks remain.

The note’s design provides partial principal protection—investors can lose a maximum of 5 %—while capturing positive performance of the weaker of NDX or SPX up to 15.2 %. Such buffering appeals to moderately risk-averse clients expecting modest equity gains through early-2027. However, the upside cap materially lags historical equity returns; if indices rally strongly, holders underperform. The lack of interim coupons and dividend pass-through further reduces total return versus direct index exposure. Estimated initial value (up to 4 % below issue price) highlights embedded costs. Because the instrument is unsecured, deterioration in UBS’s credit profile would directly affect repayment. Overall impact on UBS is immaterial given the small issuance size; impact on investors is neutral to mildly negative depending on market path and credit perceptions.

TL;DR � Attractive 95 % floor but illiquidity, capped upside and single-date risk skew the reward-to-risk profile.

From an asset-allocation view, the structure resembles a 95/5 collar on the weaker of two broad U.S. equity indices. The 18-month tenor concentrates path risk into a single observation, exposing investors to adverse end-date volatility without benefiting from interim rebounds. In rising-rate scenarios, the opportunity cost of a zero-coupon instrument increases. Illiquidity—no listing and dealer-driven secondary markets—could force exits at significant discounts. Given the cap, a simple 95 %-protected index strategy executed via options could provide better risk-adjusted exposure with daily liquidity. I view the product as moderately negative for sophisticated investors but potentially acceptable for clients prioritising downside protection over full equity participation.

UBS AG offre Note di Mercato Indicizzate a Capitale Non Garantito e Non Subordinate, collegate alla performance peggiore tra l'indice Nasdaq-100 (NDX) e l'indice S&P 500 (SPX). Il prezzo delle Note è fissato al 9 luglio 2025, con regolamento il 14 luglio 2025 e scadenza il 14 gennaio 2027 (valutazione finale l'11 gennaio 2027).

Profilo di rendimento: alla scadenza gli investitori ricevono il capitale più (i) il rendimento dell'asset sottostante meno performante se positivo, con un guadagno massimo del 15,20% (pagamento massimo $1.152); oppure (ii) il maggiore tra il rendimento dell'asset meno performante e un rendimento minimo del �5,00% se il rendimento è nullo o negativo. Di conseguenza, il capitale è protetto al 95% se detenuto fino alla scadenza, ma il potenziale guadagno è limitato.

Elementi economici chiave: prezzo di emissione $1.000; sconto di sottoscrizione $6,50 (0,65%); proventi netti $993,50. Il valore iniziale stimato è tra $959,40 e $989,40, inferiore al prezzo di emissione a causa di spread di finanziamento interni e costi di distribuzione. UBS Securities LLC è il sottoscrittore e può concedere l'intero sconto ai dealer terzi.

Considerazioni sui rischi: gli investitori assumono il rischio di credito di UBS e il rischio di mercato di ciascun indice alla data di valutazione finale. Le Note non pagano cedole, rinunciano a tutti i dividendi, non sono quotate e potrebbero presentare una liquidità secondaria limitata o assente. Le operazioni eseguite prima del regolamento richiedono un regolamento T+3. I documenti di offerta evidenziano ulteriori rischi sotto le sezioni “Rischi Chiave� e “Fattori di Rischio�.

Idoneità per gli investitori: adatte solo a investitori che tollerano fino al 5% di perdita, accettano un guadagno limitato, comprendono i prodotti strutturati e intendono mantenere l'investimento fino alla scadenza.

UBS AG ofrece Notas Vinculadas al Mercado sin garantía y no subordinadas, vinculadas al peor desempeño entre el índice Nasdaq-100 (NDX) y el índice S&P 500 (SPX). El precio de las Notas es el 9 de julio de 2025, con liquidación el 14 de julio de 2025 y vencimiento el 14 de enero de 2027 (valoración final el 11 de enero de 2027).

Perfil de rendimiento: al vencimiento, los inversionistas reciben el capital más (i) el rendimiento del activo subyacente con peor desempeño si es positivo, sujeto a una ganancia máxima del 15.20% (pago máximo $1,152); o (ii) el mayor entre el rendimiento del activo con peor desempeño y un rendimiento mínimo de �5.00% si el rendimiento es cero o negativo. Por lo tanto, el capital está protegido al 95% si se mantiene hasta el vencimiento, pero la ganancia está limitada.

Aspectos económicos clave: precio de emisión $1,000; descuento de suscripción $6.50 (0.65%); ingresos netos $993.50. El valor inicial estimado es entre $959.40 y $989.40, por debajo del precio de emisión debido a spreads internos de financiamiento y costos de distribución. UBS Securities LLC es el suscriptor y puede permitir que terceros distribuidores reciban el descuento completo.

Consideraciones de riesgo: los inversionistas asumen el riesgo crediticio de UBS y el riesgo de mercado de cada índice en la fecha de valoración final. Las Notas no pagan cupones, renuncian a todos los dividendos, no están listadas y pueden tener liquidez secundaria limitada o nula. Las operaciones realizadas antes de la liquidación requieren un arreglo de liquidación T+3. Los documentos de oferta destacan riesgos adicionales bajo “Riesgos Clave� y “Factores de Riesgo�.

Idoneidad para inversores: apropiado solo para inversionistas que puedan tolerar hasta un 5% de pérdida, acepten ganancia limitada, comprendan productos estructurados y tengan la intención de mantener hasta el vencimiento.

UBS AG� 나스�-100 지�(NDX)와 S&P 500 지�(SPX) � 성과가 � 저조한 지수를 기초� 하는 무담�, 비후순위 캡드 마켓 연계 노트� 제공합니�. 노트 가격은 2025� 7� 9�� 책정되며, 결제일은 2025� 7� 14�, 만기일은 2027� 1� 14�입니� (최종 평가일은 2027� 1� 11�).

수익 프로�: 만기 � 투자자는 원금� 함께 (i) 성적� 가� 낮은 기초자산 수익�� 양수� 경우 최대 15.20%� 최대 이익(최대 지급액 $1,152)까지 받거�; (ii) 기초자산 수익률이 0이거� 음수� 경우 최소 수익률인 �5.00%와 가� 낮은 수익� � � � 금액� 받습니다. 따라� 만기까지 보유 � 원금� 95%가 보호되지� 상승 잠재력은 제한됩니�.

주요 경제 조건: 발행가 $1,000; 인수 할인 $6.50 (0.65%); 순수� $993.50. 초기 추정 가치는 내부 자금 조달 스프레드와 배포 비용으로 인해 $959.40~$989.40� 발행가보다 낮습니다. UBS Securities LLC가 인수사이� �3� 딜러에게 전액 할인� 재허용할 � 있습니다.

위험 고려사항: 투자자는 UBS� 신용 위험� 최종 평가일의 � 지수에 대� 시장 위험� 부담합니다. 노트� 쿠폰� 지급하지 않으�, 모든 배당금을 포기하고 상장되어 있지 않으� 2� 유동성이 제한적이거나 전혀 없을 � 있습니다. 결제 � 거래� T+3 결제 조건� 필요합니�. 제공 문서에는 “주� 위험� � “위� 요소”에� 추가 위험� 명시되어 있습니다.

투자� 적합�: 최대 5% 손실� 감수� � 있고, 수익 상한� 수용하며, 구조� 상품� 이해하고 만기까지 보유� 의사가 있는 투자자에� 적합합니�.

UBS AG propose des Notes Capped Market-Linked non garanties et non subordonnées, liées à la performance la moins favorable entre l'indice Nasdaq-100 (NDX) et l'indice S&P 500 (SPX). Le prix des Notes est fixé au 9 juillet 2025, le règlement au 14 juillet 2025 et l'échéance au 14 janvier 2027 (évaluation finale le 11 janvier 2027).

Profil de rendement : à l’échéance, les investisseurs reçoivent le capital plus (i) le rendement de l’actif sous-jacent le moins performant s’il est positif, avec un gain maximal de 15,20 % (paiement maximal de 1 152 $) ; ou (ii) le plus élevé entre le rendement de l’actif sous-jacent le moins performant et un rendement minimum de �5,00 % si le rendement est nul ou négatif. Par conséquent, le capital est protégé à 95 % s’il est conservé jusqu’� l’échéance, mais le potentiel de gain est plafonné.

Principaux aspects économiques : prix d’émission 1 000 $ ; escompte de souscription 6,50 $ (0,65 %) ; produit net 993,50 $. La valeur initiale estimée se situe entre 959,40 $ et 989,40 $, inférieure au prix d’émission en raison des écarts de financement internes et des coûts de distribution. UBS Securities LLC est le souscripteur et peut accorder l’intégralité de la décote aux distributeurs tiers.

Considérations sur les risques : les investisseurs supportent le risque de crédit d’UBS et le risque de marché de chaque indice à la date d’évaluation finale. Les Notes ne versent pas de coupons, renoncent à tous les dividendes, ne sont pas cotées et peuvent présenter une liquidité secondaire limitée ou nulle. Les transactions effectuées avant le règlement nécessitent un règlement T+3. Les documents d’offre mettent en lumière des risques supplémentaires dans les sections « Risques clés » et « Facteurs de risque ».

Adéquation pour les investisseurs : approprié uniquement pour les investisseurs pouvant tolérer une perte allant jusqu’� 5 %, acceptant un gain plafonné, comprenant les produits structurés et ayant l’intention de conserver jusqu’� l’échéance.

UBS AG bietet ungesicherte, nachrangfreie Capped Market-Linked Notes an, die an die schlechter performende der beiden Indizes Nasdaq-100 (NDX) und S&P 500 (SPX) gekoppelt sind. Der Preis der Notes wird am 9. Juli 2025 festgelegt, die Abwicklung erfolgt am 14. Juli 2025 und die Fälligkeit ist am 14. Januar 2027 (Endbewertung am 11. Januar 2027).

Renditeprofil: Bei Fälligkeit erhalten Anleger den Kapitalbetrag plus (i) die Rendite des schlechter performenden Basiswerts, falls diese positiv ist, begrenzt auf einen maximalen Gewinn von 15,20 % (maximale Auszahlung $1.152); oder (ii) den höheren Wert zwischen der Rendite des schlechteren Basiswerts und einer Mindestverzinsung von �5,00 %, falls die Rendite null oder negativ ist. Dementsprechend ist das Kapital bei Halten bis zur Fälligkeit zu 95 % geschützt, allerdings ist die Gewinnchance begrenzt.

Wesentliche wirtschaftliche Fakten: Ausgabepreis $1.000; Underwriting-Discount $6,50 (0,65 %); Nettoerlös $993,50. Der geschätzte Anfangswert liegt zwischen $959,40 und $989,40, also unter dem Ausgabepreis aufgrund interner Finanzierungsspreads und Vertriebskosten. UBS Securities LLC ist der Underwriter und kann den vollen Rabatt an Drittanbieter weitergeben.

Risikohinweise: Anleger tragen das Kreditrisiko von UBS und das Marktrisiko der jeweiligen Indizes am Endbewertungstag. Die Notes zahlen keine Kupons, verzichten auf alle Dividenden, sind nicht börsennotiert und können eine begrenzte oder keine Sekundärliquidität aufweisen. Vor der Abwicklung durchgeführte Trades erfordern T+3-Abwicklungsvereinbarungen. Die Angebotsunterlagen weisen unter „Wesentliche Risiken� und „Risikofaktoren� auf weitere Risiken hin.

Geeignetheit für Anleger: Nur geeignet für Anleger, die einen Verlust von bis zu 5 % tolerieren können, eine begrenzte Aufwärtschance akzeptieren, strukturierte Produkte verstehen und die Absicht haben, bis zur Fälligkeit zu halten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ERGEN CHARLES W

(Last) (First) (Middle)
9601 S. MERIDIAN BLVD.

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EchoStar CORP [ SATS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11,272,090 D
Class A Common Stock 11,367 I I(1)
Class A Common Stock 213 I I(2)
Class A Common Stock 1,276 I I(3)
Class A Common Stock 11,566 I I(4)
Class A Common Stock 766,443 I I(5)
Class A Common Stock 2,350,696 I I(6)
Class A Common Stock 1,551,355 I I(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Common Stock (8) 06/23/2025 G(9) 6,927,672 (8) (8) Class A Common Stock 6,927,672 $0 0 I I(9)
Class B Common Stock (8) 06/23/2025 G(9) 5,267,525 (8) (8) Class A Common Stock 5,267,525 $0 5,547,408 D
Class B Common Stock (8) (8) (8) Class A Common Stock 35,190,866 35,190,866 I I(6)
Class B Common Stock (8) (8) (8) Class A Common Stock 15,104,784 15,104,784 I I(10)
Class B Common Stock (8) (8) (8) Class A Common Stock 19,038,378 19,038,378 I I(11)
Class B Common Stock (8) (8) (8) Class A Common Stock 26,500,000 26,500,000 I I(12)
Class B Common Stock (8) (8) (8) Class A Common Stock 3,306,885 3,306,885 I I(13)
Class B Common Stock (8) (8) (8) Class A Common Stock 25,000,000 25,000,000 I I(14)
1. Name and Address of Reporting Person*
ERGEN CHARLES W

(Last) (First) (Middle)
9601 S. MERIDIAN BLVD.

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CHAIRMAN
1. Name and Address of Reporting Person*
ERGEN CANTEY

(Last) (First) (Middle)
9601 S. MERIDIAN BLVD.

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) X Other (specify below)
SENIOR ADVISOR
Explanation of Responses:
1. By 401(K).
2. Held by Mrs. Cantey M. Ergen, Mr. Ergen's spouse.
3. Held by Mrs. Ergen in a 401(k) account.
4. The shares are owned beneficially by the reporting persons' child. The reporting persons disclaim beneficial ownership of the shares, except to the extent of their pecuniary interest therein.
5. The shares are held by a charitable foundation. The reporting persons are officers of the charitable foundation and share voting and dispositive power for the foundation. The reporting persons disclaim beneficial ownership of the shares, except to the extent of their pecuniary interest therein.
6. The shares are held by Telluray Holdings, LLC. Mr. Ergen and Mrs. Ergen are the managers of Telluray Holdings, LLC. Mrs. Ergen, as a manager of Telluray Holdings, LLC, has sole voting power over the Class A shares and Class B shares held by Telluray Holdings, LLC, and Mr. Ergen and Mrs. Ergen, as the managers of Telluray Holdings, LLC, share dispositive power over the Class A shares and Class B shares held by Telluray Holdings, LLC. The reporting persons disclaim beneficial ownership of the shares, except to the extent of their pecuniary interest therein.
7. These shares are beneficially owned indirectly by Mr. Ergen through nXgen Opportunities, LLC, which controls CONX Corp. The reporting persons disclaim beneficial ownership of the shares except to the extent of their pecuniary interest therein.
8. The holder of Class B shares may elect to convert any or all of their Class B shares into an equal number of Class A shares at any time for no additional consideration.
9. Pursuant to the terms of the Ergen Two-Year June 2023 SATS GRAT (the "2023 June GRAT"), on June 23, 2025, the 2023 June GRAT distributed: (i) 5,267,525 Class B shares held by the 2023 June GRAT to Mr. Ergen as an annuity payment; and (ii) the remaining 1,660,147 Class B shares to a trust, the beneficiaries of which are members of Mr. Ergen's family, and the 2023 June GRAT expired in accordance with its terms.
10. On June 26, 2023, Mr. Ergen established the Ergen Two-Year June 2023 DISH GRAT (the "2023 June DISH GRAT") and contributed a total of 89,500,000 DISH Class B shares to the 2023 June DISH GRAT. In connection with the merger (the "Merger") between EchoStar Corporation ("EchoStar") and DISH Network Corporation ("DISH") as defined in their respective SEC filings, such DISH Class B shares converted into the right to receive 31,403,491 EchoStar Class B shares. The 2023 June DISH GRAT currently holds 15,104,784 Class B shares. The 2023 June DISH GRAT is scheduled to expire in accordance with its terms on June 26, 2025. Mrs. Cantey M. Ergen serves as the trustee of the 2023 June DISH GRAT.
11. On December 22, 2023, Mr. Ergen established the Ergen Two-Year December 2023 SATS GRAT (the "2023 December GRAT") and contributed a total of 8,800,000 Class B shares and 57,000,000 DISH Class B shares to the 2023 December GRAT. In connection with the Merger, such DISH Class B shares converted into the right to receive 19,999,989 EchoStar Class B shares. After the Merger, the 2023 December GRAT held a total of 28,799,989 Class B shares. The 2023 December GRAT currently holds 19,038,378 Class B shares. The 2023 December GRAT is schedule to expire in accordance with its terms on December 22, 2025. Mrs. Cantey M. Ergen serves as trustee of the 2023 December GRAT.
12. On July 10, 2024, Mr. Ergen established the Ergen Two-Year July 2024 SATS GRAT (the "2024 July GRAT") and contributed 26,500,000 Class B shares to the 2024 July GRAT. The 2024 July GRAT is scheduled to expire in accordance with its terms on July 10, 2026. Mrs. Cantey M. Ergen serves as the trustee of the 2024 July GRAT.
13. On May 13, 2024, Mr. Ergen established the Ergen Two-Year May 2024 SATS GRAT (the "2024 May GRAT") and contributed 6,000,000 Class B shares to the 2024 May GRAT. The 2024 May GRAT currently holds 3,306,885 Class B shares and is scheduled to expire in accordance with its terms on May 13, 2026. Mrs. Cantey M. Ergen serves as the trustee of the 2024 May GRAT.
14. On May 13, 2025, Mr. Ergen established the Ergen Two-Year May 2025 SATS GRAT (the "2025 May GRAT") and contributed 25,000,000 Class B shares to the 2025 May GRAT. The 2025 May GRAT is scheduled to expire in accordance with its terms on May 13, 2027. Mrs. Cantey M. Ergen serves as the trustee of the 2025 May GRAT.
/s/ Charles W. Ergen, by Dean A. Manson, Attorney-in-Fact 06/25/2025
/s/ Cantey M. Ergen, by Dean A. Manson, Attorney-in-Fact 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What is the maximum gain on UBS’s Capped Market-Linked Notes?

The maximum gain is 15.20 %, translating to a maximum payment of $1,152 per $1,000 note.

How much principal protection do the Notes provide?

If held to maturity, investors are guaranteed at least 95 % of principal; losses are capped at 5 % (minimum return �5 %).

Which indices underlie the UBS Notes?

The Notes are linked to the Nasdaq-100 Index (NDX) and the S&P 500 Index (SPX); payout depends on the worse performer.

When do the UBS Market-Linked Notes mature?

The Notes mature on 14 January 2027, with the final valuation date set for 11 January 2027.

Does the note pay interest or dividends?

No. The Notes are zero-coupon instruments and investors forgo any dividends from the underlying indices.

What credit risk do investors face?

Payments rely solely on UBS AG’s creditworthiness; a UBS default could result in partial or full loss of investment.
Echostar Corp

NASDAQ:SATS

SATS Rankings

SATS Latest News

SATS Latest SEC Filings

SATS Stock Data

7.96B
134.06M
13.61%
93.21%
5.6%
Communication Equipment
Communications Services, Nec
United States
ENGLEWOOD